DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ceprotin (Protein C) - Current Clinical Trials


Ceprotin Related Clinical Trials

Ceprotin Treatment Registry [Completed]

Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock. [Recruiting]

Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency [Completed]

Retrospective Study to Capture Dosing and Treatment Outcome Data in Subjects With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND [Completed]

Activated Protein C and Corticosteroids for Human Septic Shock [Completed]

Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) [Completed]

Activated Protein C in Severe Acute Pancreatitis [Completed]

Administration of Protein C Concentrates in Adult Critically Ill Septic Patients [Terminated]

Activated Protein C in Acute Stroke Trial [Terminated]

Effect of Intrapulmonary Recombinant Human Activated Protein C (APC) on Coagulation and Inflammation After Lipopolysaccharide (LPS) [Completed]

Activated Protein C and Microcirculation [Completed]

Disease Modification in Toxaemia of Pregnancy [Completed]

Quantifying Airway Inflammation With Radiologic Tests [Completed]

Comparative Study of the Protein C Pathway in Septic and Non Septic Patients With Organ Failure [Terminated]

Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis [Active, not recruiting]

Activated Protein C to Treat Acute Lung Injuries [Terminated]

Evaluation of Factors II, VII, IX, X, and Proteins C and S, Following High-dose Vitamin K Supplementation [Completed]

Genetic Regulation of Surfactant Deficiency [Completed]

Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32 [Completed]

Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases [Completed]

Fluid Resuscitation in Early Septic Shock [Completed]

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women [Completed]

An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure [Completed]

Influence of Adipocytokines in Osteoarthritis [Recruiting]

Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis [Completed]

Metabolic Syndrome and Periodontitis [Recruiting]

Antihypertensive Effect of Continuous Positive Airway Pressure in Resistant Hypertensive Patients With Sleep Apnea [Completed]

Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot [Completed]

Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE) [Recruiting]

Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests [Recruiting]

Birth Control Pill vs Birth Control Patch Study [Completed]

Thrombin Generation and Thromboelastography in Non-overt DIC [Terminated]

Predicting Complications in Women With Toxaemia [Active, not recruiting]

A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers [Completed]

Synthetic vs Natural Estrogen in Combined Oral Contraception [Recruiting]

Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial [Recruiting]

The Effect of the Mini-pill on Blood Factors in Women at Increased Risk for Forming Blood Clots [Terminated]

The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots [Recruiting]

Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation [Recruiting]

Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients. [Recruiting]

Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects [Recruiting]

Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome [Recruiting]

Thromboelastography in in Patients With Sepsis [Recruiting]

Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers [Terminated]

Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer [Not yet recruiting]

Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia. [Completed]

Group Motivational Intervention in Overweight/Obese Patients [Recruiting]

FFP Versus PCC in Intracranial Hemorrhage [Recruiting]

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding [Recruiting]

Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine [Recruiting]

Safety and Dose Finding Study of Xigris in Hemodialysis Patients [Completed]

An Open Label Study of Severe Sepsis in Adults [Completed]

The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death [Completed]

Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study [Completed]

Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion [Completed]

A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation [Completed]

A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated) [Completed]

Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis [Completed]

Aralast NP in Islet Transplant [Recruiting]

A Study of an Investigational Drug, ALN-AAT, in Healthy Adult Subjects and Patients With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease [Recruiting]

A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD) [Recruiting]

Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency [Recruiting]

Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery [Not yet recruiting]

Safety Study of Gene Transfer Vector to Treat alpha1-antitrypsin Deficiency [Not yet recruiting]

Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus [Recruiting]

Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses [Recruiting]

Alpha-1 Antitrypsin Deficiency Adult Liver Study [Recruiting]

Phase II-III Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes [Recruiting]

Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) [Recruiting]

Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction [Completed]

A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease [Recruiting]

Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home [Completed]

Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation. [Recruiting]

Alpha 1 Anti-Trypsin in Treating Patients With Acute Graft-Versus-Host Disease [Recruiting]

Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD) [Completed]

Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients [Not yet recruiting]

Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients [Completed]

Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency [Recruiting]

Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency [Recruiting]

The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes [Recruiting]

International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema [Active, not recruiting]

Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency [Completed]

A Research Trial of Aralast in New Onset Diabetes (RETAIN) [Terminated]

A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II [Withdrawn]

The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency [Completed]

Alpha-1 Coded Testing(ACT) Study [Recruiting]

Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients [Completed]

The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency [Completed]

Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults [Completed]

Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE) [Completed]

Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency [Completed]

Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency [Completed]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017